EBR Online 2017: Female Reproduction

Welcome to the EBR Online 2017 Evaluation Page

Click the button below to begin the recordings activity.  At the conclusion of the session activity the access code for this course will be displayed.  Return here and enter the access code in the space provided to evaluate the activity, and claim credits commensurate with your participation.

Go to EBR Female Reproduction

Unlike other board preparation meetings, the Endocrine Society's Board Review Course offers a comprehensive mock-exam format, with case-based ABIM-style questions forming the bulk of the presentations. Each section follows the ABIM blueprint for the board exam, covering the breadth and depth of the certification/recertification examination. But you won't just get a right or wrong answer—each case will be discussed in detail, with the correct and incorrect answer options reviewed. You'll also have the opportunities to review questions asked to the faculty, compare results from other participants, and read detailed answer explanations, references, and a customized score report.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Discuss the treatment options for hyperthyroidism
  • Explain the risks and benefits of antithyroid drugs
  • Discuss potential cardiovascular risks of subclinical hyperthyroidism
  • Describe the preoperative imaging needed for papillary thyroid cancer
  • Identify thyroid cancer patients to consider for systemic therapy
  • Describe the effect of iodine deficiency and mild maternal thyroid hypofunction on fetal development
  • List the causes of persistent hypothyroidism in patients on L-thyroxine
  • Explain the effect of genetic variations on thyroid hormone replacement
  • Improve understanding of the risks and possible benefits of T4:T3 therapy
  • Diagnose and manage hyperthyroidism

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Topic Area: 
Thyroid/HPT Axis
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 1.25 ABIM MOC
  • 1.25 AMA PRA Category 1 Credits
  • 1.25 CME Certificate of Participation
Course opens: 
Course expires: 

Endocrine Board Review Chair
David S. Cooper, MD – The Johns Hopkins University School of Medicine

Faculty Authors
Richard J. Auchus, MD, PhD – University of Michigan
Carolyn B. Becker, MD – Brigham and Women’s Hospital
Daniel H. Bessesen, MD – University of Colorado School of Medicine
Andrea D. Coviello, MD – Duke University School of Medicine
Frances J. Hayes, MD – Massachusetts General Hospital
Serge A. Jabbour, MD – Thomas Jefferson University Sidney Kimmel Medical College
Michelle F. Magee, MD – MedStar Washington Hospital Center and Georgetown University School of Medicine
Mark E. Molitch, MD – Northwestern University Feinberg School of Medicine
Elizabeth N. Pearce, MD, MSc – Boston University School of Medicine
Margaret E. Wierman, MD – University of Colorado School of Medicine

Medical Editor  
Abbie L. Young, MS, CGC, ELS(D)

Disclosure Policy

The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Richard J. Auchus, MD, PhD: Contracted Research, Millendo Pharmaceuticals, Strongbridge Biopharma, Novartis Pharmaceuticals; Consultant, Alder Biopharmaceuticals, Corcept Pharmaceuticals, Diurnal Limited, Ipsen Pharmaceuticals, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Spruce Biosciences, Strongbridge Biopharma

Andrea D. Coviello, MD: Consultant and Speaker, Novo Nordisk Inc.

Serge A. Jabbour, MD: Consultant, AstraZeneca, Eli Lilly & Co., Janssen Pharmaceuticals

Mark E. Molitch, MD: Consultant, Pfizer Inc.; Consultant and Primary Investigator, Chiasma, Inc., Ipsen Pharmaceuticals, Novartis Pharmaceuticals

Elizabeth N. Pearce, MD, Msc: Primary Investigator, Sociedad Química y Minera de Chile S.A.; Speaker, IBSA Institut Biochimique SA, Merck Serono

The following faculty reported no relevant financial relationships: Carolyn B. Becker, MD; David S. Cooper, MD; Frances J. Hayes, MD; Michelle F. Magee, MD; Margaret E. Wierman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 1.25 ABIM MOC
  • 1.25 AMA PRA Category 1 Credits
  • 1.25 CME Certificate of Participation

Access the evaluation through this tab.  To start, users must...

1.  Be logged into personal Endocrine Society account

     This can be done through the Login button above or in the top right corner of the page.

     When logged in, you will see your name in the blue ribbon at the top of the page.

2.  Enter the evaluation access code which is available at the conclusion of EBR 2017 session recordings

3.  After completing steps 1 & 2 click the blue Start button to begin the evaluation